Using platelet-rich plasma to treat parosmia
Official title: Randomized Clinical Trial of Intranasal Injection of Platelet-Rich Plasma for Treatment of Parosmia
Run by Stanford University · NCT06283745 · Data updated 2026-11-12
This study is testing whether injections of platelet-rich plasma can help people with parosmia, a condition that causes distorted smells, feel better after having upper respiratory infections.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Stanford University Academic / other |
| Locations | 1 site (Palo Alto, California) |
| Status | Recruiting |
| Started | November 23, 2024 |
| Main results expected | March 22, 2027 |
| Study ends | March 22, 2027 |
| Registry record updated | November 22, 2024 |
| Trial ID | NCT06283745 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with parosmia resulting from upper respiratory infections and who have been experiencing symptoms for at least 6 months but less than 24 months.
✕Probably not a fit
Patients with olfactory loss due to trauma, chronic sinusitis, structural abnormalities, or neurodegenerative diseases are unlikely to benefit from this treatment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effectiveness of intranasal injections of platelet-rich plasma (PRP) in treating parosmia, a condition characterized by distorted smell. PRP, derived from the patient's own blood, is known for its anti-inflammatory and regenerative properties. The study will involve patients who have experienced olfactory distortion due to upper respiratory infections and will assess improvements in their olfactory function. Participants will also engage in concurrent olfactory training as part of the standard care.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from parosmia by restoring their sense of smell.
How similar studies have gone: Previous studies have shown safety and efficacy of PRP in treating olfactory loss, indicating potential for success in this novel application for parosmia.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients \>= 18 years of age * Patients who have qualitative olfactory distortion * Etiology of qualitative olfactory distortion is due to upper respiratory infection * Quantitative score under the 10th percentile on the SSParoT (HedRang and HedDir) * Quantitative score ≥ 8 on the QOD. * At least 6 months of parosmia but less than 24 months * Patients can have been previously treated with oral and topical steroids but this is not a requirement * Patients will receive concurrent olfactory training - the practice of smelling strong odors (standard of care) * Be able to read and understand English * Be able and willing to provide Informed Consent Exclusion Criteria: * Patients \< 18 years of age, pregnant females, patients who have structural abnormalities on nasal endoscopy or radiographic imaging that would prevent injection into the olfactory cleft * Olfactory loss due to trauma, chronic sinusitis / inflammation / polyps, neoplasms, or neurodegenerative diseases or patients who have had olfactory loss \> 24 months * Patients with bleeding disorders or on blood thinners such as coumadin and plavix
Where it's running
-
Stanford Sinus Center / Stanford University School of Medicine
Palo Alto, California, United States Recruiting
Study contacts
- Principal investigator: Zara Patel, MD — Stanford Otolaryngology - Head and Neck Surgery
- Study coordinator: Homer Abaya, BS
- Email: habaya@stanford.edu
- Phone: (650) 725-6500
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
A digital tool to help decide about an ICD
We’re testing a patient-friendly online aid to help people with advanced heart failure decide whether an implantable cardioverter-defibrillator (ICD) is right for them.
-
Wise Interventions to Boost Pediatric Weight Control
This study tests whether adding two quick social-psychology activities (growth mindset and self-affirmation) to a family-based weight management program helps 10–15 year-olds with obesity achieve better BMI outcomes over 12 months.
-
Reducing Chronic Pain After Cesarean Delivery
A single-session pain-relief class called Empowered Relief is tested alongside standard postpartum care to see if it helps women who have ongoing pain after cesarean delivery.
-
Human-created animated art vs AI-created art: does it change how you feel right away?
This online trial tests whether watching a human-made animated art film or an AI-made one, or doing nothing, quickly changes mood or sense of connection in U.S. adults.
-
SMILE in one eye vs Ray tracing-guided LASIK in the fellow eye
This study tests two laser vision correction methods—SMILE in one eye and ray-tracing guided LASIK in the other eye—to see which provides better vision and quality of life for adults with myopia and astigmatism.
-
Voices Illuminating Solutions for Outdoor Workers’ Needs and Safety
This trial tests whether adding bilingual Our Voice photovoice participation to standard bilingual occupational health education helps outdoor workers in California better address climate-related health risks.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.